Freeline is hiring

11th Jun 2018 By admin

Freeline is expanding its team. If you are excited about our mission, please see our careers sections for current vacancies.

To see the latest vacancies please click here

Latest News

Freeline secures over £88 million of funding

18th Jun 2018 By greg

London, 19 June 2018 – Freeline Therapeutics Ltd (“Freeline”), a clinical stage company focused on treatment of chronic systemic diseases with liver targeted adeno-associated virus (AAV) gene therapy, announces...

More >

Freeline is hiring

11th Jun 2018 By admin

Freeline is expanding its team. If you are excited about our mission, please see our careers sections for current vacancies. To see the latest vacancies please click here

More >

FREELINE announces viral vector manufacturing technology collaboration with Cell and Gene Therapy Catapult

22nd Jan 2018 By admin

Freeline will develop a ‘next-generation’ therapy platform at CGT Catapult’s UK-based large-scale GMP manufacturing centre. The company will further develop proprietary viral vector manufacturing technology for bleeding and other...

More >

Freeline Platform

Our proprietary and highly optimised platform is aiming to maximise clinical benefit for patients

Learn More >

Gene Therapy for Haemophilia

Gene therapy has the potential to transform people's lives by safely and continuously delivering clotting proteins to the blood

Learn More >

Freeline careers

Find out more about life at Freeline and current vacancies in our careers section

Learn More >